Biopharma Science Product News | Page 197 | Technology Networks

We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Biopharma

Biopharma

Stay up to date on the topics that matter to you

Featured Products

Biopharma, Biotechnology, Antibodies, Biomarkers, Cell-Based Assays, Drug Delivery, Immunology, Drug Discovery

ZE5 Cell Analyzer

Biopharma, Biotechnology, Antibodies, Biomarkers, Cell-Based Assays, Drug Delivery, Immunology, Drug Discovery

Anti-Idiotypic Antibodies

Therapeutic Protein Development, Protein Expression System, Gene Expression Technology, Biopharmaceutical Manufacturing, Protein Discovery to Commercialization, Therapeutic Protein Production, Gene Expression for Biologics, Bioprocessing Solutions, GS Gene Expression System, Protein Therapeutics, Commercial-Scale Protein Production, Protein Expression Platform, Biopharma Gene Expression, High-Yield Protein Production, Biotherapeutic Development

GS Gene Expression System®: Taking Your Therapeutic Protein from Discovery to Commercial

IBD Drug Development Tools: TL1A Recombinant Proteins and Overexpression Cell Lines

AGLink DAR2&4 Site-Specific Conjugation Kits for Early-Stage Research and Biological Experiments in the Field of Conjugated Drugs

GeneArt Protein Expression & Purification Services: An Extension of Your Bench

Product News

Oncodesign Offers World’s Most Comprehensive Collection of Patient-derived Colorectal Tumor Models

Collection of 53 models offers full range of characterization.

Proteros and CHDI Establish Discovery Services Collaboration to Address Huntington’s Disease

Proteros entered into a service agreement with CHDI, under which Proteros will provide structure-based drug discovery services to CHDI.

Using Roche’s CASY Cell Counter and Analyzer for Proliferation and Viability Measurement in Cancer Studies

CASY Cell Counter and Analyzer from Roche Applied Science to identify the specific anticancer properties of a therapeutic substance in BJAB cells.

Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs

New U.S. patent adds to four others received over last six months.

Gyros Announces Availability of Protein A immunoassay Kit for Gyrolab xP Workstations

The new kit enables scientists to test for the presence of Protein A, an impurity that can occur in any antibody-based therapeutic that has been purified using affinity chromatography.

Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.

Dynavax Reports Additional Positive Phase 1B Immunogenicity Data for Hepatitis B Therapy Candidate

The data for DV-601 has reported in a poster session Saturday, February 19 at the 21st Conference of the APASL 2011 in Bangkok, Thailand.

Synexus Support Vaccines Trials with Dedicated Team

Company has created vaccines team to help pharma and biotech companies find the thousands of patients they need for their late phase trials.

Dynavax Reports New Phase 1a and Phase 1b Data for Universal Flu Vaccine Candidate

The data is reported in Geneva, Switzerland at the world health organization 7th meeting on evaluation of pandemic influenza prototype vaccines.

Patents Granted in Key Territories as Novexatin® Moves Closer to Further Clinical Development and Commercialization

NovaBiotics has further secured the global intellectual property position of Novexatin® through recent patent grants in the US, EU and other territories worldwide.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter